An Old TB Vaccine Finds New Life in Coronavirus Trials

Studies are underway to test whether giving a shot of BCG vaccine could protect doctors and nurses against COVID-19.

Written byAnthony King

| 8 min read

Save for Later

bcg tuberculosis tb sars-cov-2 covid-19 coronavirus pandemic vaccine nonspecific effects trained immunity innate immune system response

Listen with Speechify

0:00

8:00

ABOVE: MODIFIED FROM © ISTOCK.COM, VISUAL GENERATION, FAIRYWONG, WENMEI ZHOU; © TASHA DIBIAGIO

One of the oldest vaccines could protect us against our newest infectious disease, COVID-19. The vaccine has been given to babies to protect them against tuberculosis for almost a century, but has been shown to shield them from other infections too, prompting scientists to investigate whether it can protect against the coronavirus.

This Bacille Calmette-Guérin (BCG) vaccine, named after two French microbiologists, consists of a live weakened strain of Mycobacterium bovis, a cousin of M. tuberculosis, the bacterium that causes tuberculosis. BCG has been given to more than 4 billion individuals, making it the most widely administered vaccine globally.

Because BCG protects babies against some viral infections in addition to TB, researchers decided to compare data from countries with and without mandatory BCG vaccination to see if immunization policies are linked to the number or severity of ...

Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!

Join for free today

Already a member?

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Anthony King
Anthony King is a freelance science journalist based in Dublin, Ireland, who contributes to The Scientist. He reports on a variety of topics in chemical and biological sciences, as well as science policy and health. His articles have appeared in Nature, Science, Cell, Chemistry World, New Scientist, the Irish Times, EMBO Reports, Chemistry & Industry, and more. He is President of the Irish Science & Technology Journalists Association.
View Full Profile